CDER “De-Layering” In Second Half 2003, Following Incorporation Of CBER
FDA's Center for Drug Evaluation & Research will undergo a "de-layering" in mid- to late 2003 as part of FDA's overall review of management functions
FDA's Center for Drug Evaluation & Research will undergo a "de-layering" in mid- to late 2003 as part of FDA's overall review of management functions